表紙
市場調查報告書

微創腦神經外科系統的全球市場:2020-2030年

Global Minimally Invasive Neurosurgical Systems Market: Analysis and Forecast, 2020-2030

出版商 BIS Research Inc. 商品編碼 968661
出版日期 內容資訊 英文 210 Pages
商品交期: 最快1-2個工作天內
價格
微創腦神經外科系統的全球市場:2020-2030年 Global Minimally Invasive Neurosurgical Systems Market: Analysis and Forecast, 2020-2030
出版日期: 2020年10月26日內容資訊: 英文 210 Pages
簡介

全球微創腦神經外科系統的市場規模在預測期間內預計以11.8%的年複合成長率發展,從2019年的4億1770萬美元,成長到2030年12億3760萬美元的規模。對比剖腹手術安全的選項的愛好變化,對更正確動作的手術器具的愛好擴大,手術的價格性提高,AI,AR,觸覺技術,遠隔手術等領域的技術進步等要素促進該市場的成長。同時,有技術的專家不足成為市場進一步成長的課題。

本報告提供全球微創腦神經外科系統的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,相關法律,專利趨勢,市場規模的變化、預測,產品類型、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 產品定義

第2章 調查範圍

第3章 調查手法

第4章 競爭情形

  • 主要的展開、策略
  • 市場佔有率分析
  • 成長佔有率分析

第5章 產業分析

  • 法律規章
  • COVID-19的影響
  • 被盼望的技術開發
  • 專利分析
  • 微創手術:市場機會分析

第6章 市場動態

  • 影響分析
  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第7章 市場方案

  • 全球市場預測
  • 主要調查結果
  • 前提條件、規定

第8章 市場分析、預測:各產品類型

  • 市場概要
  • 神經顯微鏡檢驗
  • 神經導航
    • 光神經導航系統
    • 電磁神經導航系統
  • 神經科學用內視鏡檢驗
    • 硬式鏡子
    • 軟性鏡子
  • 腦神經外科機器人工學
    • 系統(資本設備)
    • 設備、配件
    • 服務

    第9章 市場分析、預測:各地區、主要國家

    • 市場概要
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
      • 荷蘭
      • 瑞士
      • 其他
    • 亞太地區
      • 日本
      • 中國
      • 韓國
      • 印度
      • 澳洲、紐西蘭
      • 新加坡
      • 其他
    • 其他地區(南美、中東、非洲)

第10章 企業簡介

  • Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
  • Microbot Medical, Inc.
  • Synaptive Medical, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Olympus Corporation
  • Renishaw plc
  • Medtronic plc
  • Leica Microsystems (Danaher Corporation)
  • Carl Zeiss AG
  • Haag-Streit Holding AG (Metall Zug AG)
  • Karl Storz SE & Co. KG
  • Brainlab AG
  • Monteris Medical Corporation
目錄
Product Code: BHR0856SA

"Global Minimally Invasive Neurosurgical Systems Market to Reach $1.23 Billion by 2030."

Market Report Coverage - Minimally Invasive Neurosurgical Systems

Market Segmentation

  • Neuromicroscopy
  • Neuronavigation
    • Optical Neuronavigation Systems
    • Electromagnetic Neuronavigation Systems
  • Neuroendoscopy
    • Rigid Neuroendoscopy Systems
    • Flexible Neuroendoscopy Systems
  • Neurosurgical Robotics
    • Systems
    • Instruments and Accessories
    • Services

Regional Segmentation

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Rest-of-Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia and New Zealand
    • Singapore
    • Rest-of-Asia-Pacific
  • Rest-of-the-World (Latin America and Middle East and Africa)

Growth Drivers

  • Increasing Elderly Population on the Global Level
  • Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
  • Availability of Technological Advanced Products in the Field of Neurosurgical Procedures

Market Challenges

  • Shortage of Skilled Professionals
  • Restrictive Reimbursement Landscape

Market Opportunities

  • Development of Long-Distance Teleoperated Surgical Robotic Systems
  • Development of Augmented Reality in the Operating Field

Key Companies Profiled

Corindus vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation

Key Questions Answered in this Report:

  • What is the current market size and future potential of the minimally invasive neurosurgical products?
  • What is the current market share and growth share of the different products in the market?
  • What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive neurosurgical systems?
  • What are the major market drivers, restraints, and opportunities in the global minimally invasive neurosurgical systems market?
  • What is the impact of the COVID-19 pandemic on the market?
  • Which technology is being researched and worked upon to improve the neurosurgical systems?
  • Who are the leading players holding dominating shares in the global minimally invasive neurosurgical systems market?
  • What are the key development and strategies incorporated by the players of the global minimally invasive neurosurgical systems market to sustain the competition and retain their supremacy?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive neurosurgical systems market?

Overview on the Global Minimally Invasive Neurosurgical Systems Market

Technological advancements in neurosurgical systems and instruments have led to major breakthroughs and disruptive phases in the healthcare landscape across the world. The inventions of the digital camera further aiding in the visualization of the operating field and smaller surgical instruments, which can be passed through endoscopes, produces less trauma to a patient due to small incisions on the skull. Thus, the preference for minimally invasive neurosurgeries continued to grow over the decades, this led to the emergence of robotic-assisted surgeries because of the need for millimeter accuracy and precision, which cannot be done freehand by neurosurgeons. The idea of robotic-assisted neurosurgical procedures is being driven by the increasing need for using multiple surgical instruments through multiple access ports of the endoscopes to support minimally invasive neurosurgeries.

Global Minimally Invasive Neurosurgical Systems Market Forecast, 2020-2030

The global minimally invasive neurosurgical systems market was valued at $417.7 million in 2019 and is anticipated to reach $1,237.6 million by 2030, growing at a CAGR of 11.8% during the forecast period 2020-2030.

The evolution of technologies and methodologies has a huge impact on the global minimally invasive neurosurgical systems market. Several factors such as the shift in preference for safer options than open brain surgeries, increasing preference for surgical instruments with more dexterity, increasing affordability of the procedure, and technological advances in the field of Artificial Intelligence (AI), Augmented Reality (AR), haptics, and telesurgery are expected to play a key role in the growth of the market. The neurosurgical robot is likely to grow because of a more connected interface, motion scaling, and tremor filtration. The high installation and maintenance cost of neurosurgical robotic systems is one of the key factors restraining the growth in the adoption of surgical robotics technology. The neurosurgical systems like neuroendoscopy, neuronavigation, and neuromicroscopy will see steady growth due to the upgradation in the technologies they use. Additionally, a lack of skilled professionals will be a challenge to the growth of this market.

Competitive Landscape

The global minimally invasive neurosurgical systems market consists of large and new entrant manufacturers and vendors. Presently, with the increasing adoption of neurosurgical robotics systems and neuronavigation systems in healthcare, the manufacturers in the market have a decent number of opportunities to expand their offerings and to make a strong foothold in the market.

During January 2015- August 2020, the market witnessed approximately 12 new offerings, six partnerships, alliances and business expansions, 17 regulatory and legal approvals, four funding activities, and five mergers and acquisitions. Most of the manufacturers in the market acquires and partnerships with not only other companies but also the university and research institutions as the key strategies to develop a new version of neurosurgical systems to attain a strong financial position in the market.

The key players contributing to the global minimally invasive neurosurgical systems market are Corindus Vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation.

Table of Contents

1 Product Definition

2 Scope of Research Study

  • 2.1 Key Questions Answered in the Report
  • 2.2 Forecast Period Selection Criteria

3 Research Methodology

  • 3.1 Primary Research
  • 3.2 Secondary Research
  • 3.3 Data Sources and Categorization
  • 3.4 Market Estimation and Forecast Methodology
  • 3.5 Data Triangulation

4 Competitive Landscape

  • 4.1 Key Developments and Strategies
    • 4.1.1 Regulatory and Legal
    • 4.1.2 New Offerings
    • 4.1.3 Partnerships, Alliances, and Business Expansions
    • 4.1.4 Mergers and Acquisitions
    • 4.1.5 Funding Activities
  • 4.2 Market Share Analysis
    • 4.2.1 Company
    • 4.2.2 Neuromicroscopy
    • 4.2.3 Neuronavigation
    • 4.2.4 Neuroendoscopy
    • 4.2.5 Neurosurgical Robotics
  • 4.3 Growth Share Analysis
    • 4.3.1 Product Type
    • 4.3.2 Region

5 Industry Insights

  • 5.1 Legal Regulations
    • 5.1.1 U.S.
    • 5.1.2 European Union (EU)
    • 5.1.3 China
    • 5.1.4 Japan
  • 5.2 Impact of COVID-19
  • 5.3 Awaited Technological Developments
    • 5.3.1 Age of Augmented Reality (AR) Integration
  • 5.4 Patent Analysis
    • 5.4.1 Patent Filing Trends
    • 5.4.2 Patent Filing Trend (by Product Type)
    • 5.4.3 Patent Filing Trend (by Country)
    • 5.4.4 Impact of Patent Expiration
  • 5.5 Minimally Invasive Surgeries: Opportunity Analysis
    • 5.5.1 Pre-COVID-19 Scenario
    • 5.5.2 Post-COVID-19 Scenario

6 Market Dynamics

  • 6.1 Impact Analysis
  • 6.2 Market Drivers
    • 6.2.1 Increasing Elderly Population on the Global Level Propels the Demand for Minimally Invasive Neurosurgical Procedures
    • 6.2.2 Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
    • 6.2.3 Availability of Technological Advanced Products in the Field of Neurosurgical Procedures
  • 6.3 Market Restraints
    • 6.3.1 Lack of Skilled Professionals
    • 6.3.2 Restrictive Reimbursement Framework
  • 6.4 Market Opportunities
    • 6.4.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
      • 6.4.1.1 Advantages of Long-Distance Teleoperated Surgical Robotics

7 Global Minimally Invasive Neurosurgical Systems Market Scenario

  • 7.1 Global Market Outlook, 2019-2030
  • 7.2 Key Findings
  • 7.3 Assumptions and Limitations

8 Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030

  • 8.1 Market Overview
  • 8.2 Neuromicroscopy
    • 8.2.1 Overview
    • 8.2.2 Market Size and Forecast
  • 8.3 Neuronavigation
    • 8.3.1 Overview
    • 8.3.2 Market Size and Forecast
    • 8.3.3 Optical Neuronavigation Systems
    • 8.3.4 Electromagnetic Neuronavigation Systems
  • 8.4 Neuroendoscopy
    • 8.4.1 Overview
    • 8.4.2 Market Size and Forecast
    • 8.4.3 Rigid Neuroendoscopy Systems
    • 8.4.4 Flexible Neuroendoscopy Systems
  • 8.5 Neurosurgical Robotics
    • 8.5.1 Overview
    • 8.5.2 Market Size and Forecast
    • 8.5.3 Systems (Capital Equipment)
    • 8.5.4 Instruments and Accessories
    • 8.5.5 Services

9 Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019-2030

  • 9.1 Market Overview
  • 9.2 North America
    • 9.2.1 Opportunity Assessment
    • 9.2.2 Market Size and Forecast
    • 9.2.3 U.S.
    • 9.2.4 Canada
  • 9.3 Europe
    • 9.3.1 Opportunity Assessment
    • 9.3.2 Market Size and Forecast
    • 9.3.3 Germany
    • 9.3.4 France
    • 9.3.5 U.K.
    • 9.3.6 Italy
    • 9.3.7 Spain
    • 9.3.8 Netherlands
    • 9.3.9 Switzerland
    • 9.3.10 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Opportunity Assessment
    • 9.4.2 Market Size and Forecast
    • 9.4.3 Japan
    • 9.4.4 China
    • 9.4.5 South Korea
    • 9.4.6 India
    • 9.4.7 Australia and New Zealand
    • 9.4.8 Singapore
    • 9.4.9 Rest-of-Asia-Pacific
  • 9.5 Rest-of-the-World (Latin America and Middle East and Africa)
    • 9.5.1 Opportunity Assessment
    • 9.5.2 Market Size and Forecast

10 Company Profiles

  • 10.1 Overview
  • 10.2 Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
    • 10.2.1 Company Overview
    • 10.2.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.2.3 Financials
    • 10.2.4 SWOT Analysis
  • 10.3 Microbot Medical, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.3.3 SWOT Analysis
  • 10.4 Synaptive Medical, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.4.3 SWOT Analysis
  • 10.5 Stryker Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.5.3 Financials
    • 10.5.4 SWOT Analysis
  • 10.6 Zimmer Biomet Holdings, Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.6.3 Financials
    • 10.6.4 SWOT Analysis
  • 10.7 B. Braun Melsungen AG
    • 10.7.1 Company Overview
    • 10.7.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.7.3 Financials
    • 10.7.4 SWOT Analysis
  • 10.8 Olympus Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.8.3 Financials
    • 10.8.4 SWOT Analysis
  • 10.9 Renishaw plc
    • 10.9.1 Company Overview
    • 10.9.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.9.3 Financials
    • 10.9.4 SWOT Analysis
  • 10.1 Medtronic plc
    • 10.10.1 Company Overview
    • 10.10.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.10.3 Financials
    • 10.10.4 SWOT Analysis
  • 10.11 Leica Microsystems (Danaher Corporation)
    • 10.11.1 Company Overview
    • 10.11.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.11.3 Financials
    • 10.11.4 SWOT Analysis
  • 10.12 Carl Zeiss AG
    • 10.12.1 Company Overview
    • 10.12.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.12.3 Financials
    • 10.12.4 SWOT Analysis
  • 10.13 Haag-Streit Holding AG (Metall Zug AG)
    • 10.13.1 Company Overview
    • 10.13.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.13.3 Financials
    • 10.13.4 SWOT Analysis
  • 10.14 Karl Storz SE & Co. KG
    • 10.14.1 Company Overview
    • 10.14.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.14.3 SWOT Analysis
  • 10.15 Brainlab AG
    • 10.15.1 Company Overview
    • 10.15.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.15.3 SWOT Analysis
  • 10.16 Monteris Medical Corporation
    • 10.16.1 Company Overview
    • 10.16.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
    • 10.16.3 SWOT Analysis

List of Tables

  • Table 1: Impact of Market Drivers
  • Table 2: Impact of Market Restraints
  • Table 5.1: Minimally Invasive Neurosurgical Systems: FDA Product Classification
  • Table 6.1: Impact Analysis: Market Drivers
  • Table 6.2: Impact Analysis: Market Restraints
  • Table 9.1: North America Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.2: U.S. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.3: Canada Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.4: Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.5: Germany Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.6: France Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.7: U.K. Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.8: Italy Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.9: Spain Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.10: Netherlands Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.11: Switzerland Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.12: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.13: Asia-Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.14: Japan Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.15: China Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.16: South Korea Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.17: India Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.18: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.19: Singapore Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.20: Rest-of-Asia Pacific Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
  • Table 9.21: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030

List of Figures

  • Figure 1: Evolution of Surgery
  • Figure 2: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 3: Company Share Analysis, 2019
  • Figure 4: Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019 and 2030
  • Figure 5: Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019, 2025, and 2030
  • Figure 6: Global Minimally Invasive Neurosurgical Systems Market Growth (by Region), 2019, 2025, and 2030
  • Figure 7: Key Strategies Incorporated by the Key Players (January 2015-August 2020)
  • Figure 3.1: Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Data Triangulation
  • Figure 3.5: Bottom-Up Approach
  • Figure 4.1: Share of Key Developments and Strategies (by Category), January 2015-August 2020
  • Figure 4.2: Number of Key Developments and Strategies (by Year), January 2015-August 2020
  • Figure 4.3: Number of Key Developments and Strategies (by Regulatory and Legal Activities), January 2015-August 2020
  • Figure 4.4: Number of Key Developments and Strategies (by New Offerings), January 2015-August 2020
  • Figure 4.5: Market Share Analysis (by Company), 2019
  • Figure 4.6: Growth Share Analysis (by Product Type), 2019-2030
  • Figure 4.7: Growth Share Analysis (by Region), 2019-2030
  • Figure 5.1: Regulatory Process for Medical Devices in the U.S.
  • Figure 5.2: MDR Transitional Provisions (EU)
  • Figure 5.3: Timeline and Impact of MDR (EU)
  • Figure 5.4: Regulatory Process for Medical Devices in European Union
  • Figure 5.5: Regulatory Process for Medical Devices in the China
  • Figure 5.6: Regulatory Process for Medical Devices in Japan
  • Figure 5.7: Patent Filing Trend (by Year), January 2015-September 2020
  • Figure 5.8: Percentage of Patent Filed in Different Technological Area, (January 2015-September 2020
  • Figure 5.9: Patent Filing Trend (by Year), January 2015-September 2020
  • Figure 5.10: Minimally Invasive Surgery - Pre-COVID-19 Scenario
  • Figure 5.11: Number of Elective Surgical Procedures Cancelled due to COVID-19 (by Region)
  • Figure 6.1: Market Dynamics
  • Figure 6.2: Global Prevalence of Neurological Disorders (by Age-Group), 2013-2017
  • Figure 6.3: Global Deaths due to Neurological Disorders (by Age-Group), 2013-2017
  • Figure 6.4: Advantages of Minimally Invasive Surgical Procedures
  • Figure 6.5: Overview of Telesurgery Workflow
  • Figure 6.6: Telesurgery: Bridging the Gap Associated with Healthcare Accessibility
  • Figure 7.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 7.2: Global Market Incremental Revenue Opportunity Analysis, 2019-2030
  • Figure 8.1: Global Minimally Invasive Neurosurgical Systems Market (by Product Type)
  • Figure 8.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Product Type), 2019 and 2030
  • Figure 8.3: Global Neuromicroscopy Market, 2019-2030
  • Figure 8.4: Market Segmentation:
  • Figure 8.5: Global Neuronavigation Market, 2019-2030
  • Figure 8.6: Global Neuronavigation Market Share, 2019 and 2030
  • Figure 8.7: Global Optical Neuronavigation Systems Market, 2019-2030
  • Figure 8.8: Global Electromagnetic Neuronavigation Systems Market, 2019-2030
  • Figure 8.9: Market Potential of Endoscopy Systems (by Application)
  • Figure 8.10: Market Segmentation:
  • Figure 8.11: Global Neuroendoscopy Market, 2019-2030
  • Figure 8.12: Global Neuroendoscopy Market Share, 2019 and 2030
  • Figure 8.13: Global Rigid Neuroendoscopy Systems Market, 2019-2030
  • Figure 8.14: Global Flexible Neuroendoscopy Systems Market, 2019-2030
  • Figure 8.15: Market Segmentation:
  • Figure 8.16: Global Neurosurgical Robotics Market, 2019-2030
  • Figure 8.17: Global Neurosurgical Robotics Market Share, 2019 and 2030
  • Figure 8.18: Global Neurosurgical Robotics Market (by System), 2019-2030
  • Figure 8.19: Global Neurosurgical Robotics Market (Instruments and Accessories), 2019-2030
  • Figure 8.20: Global Neurosurgical Robotics Market (by Service), 2019-2030
  • Figure 9.1: Global Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.2: Global Minimally Invasive Neurosurgical Systems Market Share (by Region), 2019 and 2030
  • Figure 9.3: North America: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.4: North America Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.5: North America Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
  • Figure 9.6: U.S. Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.7: Canada Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.8: Europe: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.9: Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.10: Europe Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
  • Figure 9.11: Germany Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.12: France Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.13: U.K. Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.14: Italy Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.15: Spain Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.16: Netherlands Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.17: Switzerland Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.18: Rest-of-Europe Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.19: Asia-Pacific: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.20: Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.21: Asia-Pacific Minimally Invasive Neurosurgical Systems Market Share (by Country), 2019 and 2030
  • Figure 9.22: Japan Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.23: China Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.24: South Korea Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.25: India Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.26: Australia and New Zealand Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.27: Singapore Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.28: Rest-of-Asia-Pacific Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 9.29: Rest-of-the-World: Incremental Revenue Opportunity, 2019-2030
  • Figure 9.30: Rest-of-the-World Minimally Invasive Neurosurgical Systems Market, 2019-2030
  • Figure 10.1: Global Minimally Invasive Neurosurgical Systems Market: Key Companies
  • Figure 10.2: Corindus Vascular Robotics, Inc.: Overall Financials ($Million), 2016-2018
  • Figure 10.3: Corindus Vascular Robotics, Inc.: Net Revenue (by Segment), 2016-2018
  • Figure 10.4: Corindus Vascular Robotics, Inc.: Net Revenue (by Region), 2016-2018
  • Figure 10.5: Stryker Corporation: Overall Financials ($Million), 2017-2019
  • Figure 10.6: Stryker Corporation: Net Revenue (by Segment), 2017-2019
  • Figure 10.7: Stryker Corporation: Net Revenue (by Region), 2017-2019
  • Figure 10.8: Zimmer Biomet Holdings, Inc.: Overall Financials ($Million), 2017-2019
  • Figure 10.9: Zimmer Biomet Holdings, Inc.: Net Revenue (by Product Category), 2017-2019
  • Figure 10.10: Stryker Corporation: Net Revenue (by Region), 2017-2019
  • Figure 10.11: B. Braun Melsungen AG: Overall Financials ($Million), 2017-2019
  • Figure 10.12: B. Braun Melsungen AG: Net Revenue (by Segment), 2017-2019
  • Figure 10.13: B. Braun Melsungen AG: Net Revenue (by Region), 2017-2019
  • Figure 10.14: Olympus Corporation: Overall Financials ($Million), 2018-2020
  • Figure 10.15: Olympus Corporation: Net Revenue (by Segment), 2018-2020
  • Figure 10.16: Olympus Corporation: Net Revenue (by Region), 2018-2020
  • Figure 10.17: Renishaw plc: Overall Financials ($Million), 2018-2020
  • Figure 10.18: Renishaw plc: Net Revenue (by Segment), 2018-2020
  • Figure 10.19: Renishaw plc: Net Revenue (by Region), 2018-2020
  • Figure 10.20: Medtronic plc: Overall Financials ($Million), 2018-2020
  • Figure 10.21: Medtronic plc: Net Revenue (by Segment), 2018-2020
  • Figure 10.22: Medtronic plc: Net Revenue (by Region), 2018-2020
  • Figure 10.23: Danaher Corporation: Overall Financials ($Million), 2017-2019
  • Figure 10.24: Danaher Corporation: Net Revenue (by Segment), 2017-2019
  • Figure 10.25: Danaher Corporation: Net Revenue (by Region), 2018-2019
  • Figure 10.26: Carl Zeiss AG: Overall Financials ($Million), 2017-2019
  • Figure 10.27: Carl Zeiss AG: Net Revenue (by Segment), 2017-2019
  • Figure 10.28: Carl Zeiss AG: Net Revenue (by Region), 2018-2019
  • Figure 10.29: Metall Zug AG: Overall Financials ($Million), 2017-2019
  • Figure 10.30: Metall Zug AG: Net Revenue (by Segment), 2017-2019
  • Figure 10.31: Metall Zug AG: Net Revenue (by Region), 2018-2019